Joel Greenblatt Biogen Inc. Transaction History

Gotham Asset Management, LLC

$7.56 Billion
Q2 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Biogen Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 23,557 shares of BIIB stock, worth $4.09 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

23,557

Holding current value

$4.09 Million

% of portfolio

0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $4.49 Million - $5.58 Million	23,557 New	23,557 $5.46 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $3.51 Million - $4.22 Million	-15,766 Reduced 81.06%	3,684 $953,000
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $2.96 Million - $3.34 Million	-11,698 Reduced 37.56%	19,450 $5 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $3.1 Million - $3.59 Million	11,274 Added 56.73%	31,148 $8.87 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $386,122 - $439,971	1,505 Added 8.19%	19,874 $5.53 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $1.83 Million - $2.22 Million	7,253 Added 65.25%	18,369 $5.09 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $979,485 - $1.35 Million	-5,031 Reduced 31.16%	11,116 $2.97 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $1.71 Million - $2.03 Million	-9,092 Reduced 36.02%	16,147 $3.29 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $2.94 Million - $3.7 Million	15,155 Added 150.29%	25,239 $5.32 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $819,099 - $1.05 Million	-3,658 Reduced 26.62%	10,084 $2.42 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $3.07 Million - $4 Million	10,832 Added 372.23%	13,742 $3.89 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $3.09 Million - $4.94 Million	-11,914 Reduced 80.37%	2,910 $1.01 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $1.99 Million - $2.33 Million	-8,184 Reduced 35.57%	14,824 $4.15 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $1.9 Million - $2.86 Million	-8,035 Reduced 25.88%	23,008 $5.63 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $18.2 Million - $21 Million	-68,839 Reduced 68.92%	31,043 $8.81 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $8.82 Million - $11.7 Million	-34,093 Reduced 25.45%	99,882 $26.7 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $6.93 Million - $8.8 Million	-25,791 Reduced 16.14%	133,975 $42.4 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $3.36 Million - $4.64 Million	-15,261 Reduced 8.72%	159,766 $47.4 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $4.29 Million - $4.81 Million	19,741 Added 12.71%	175,027 $40.8 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $884,615 - $975,098	4,034 Added 2.67%	155,286 $36.3 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $9.71 Million - $15.2 Million	44,817 Added 42.11%	151,252 $35.8 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $7.57 Million - $9.58 Million	27,164 Added 34.27%	106,435 $32 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $1.71 Million - $2.24 Million	-5,836 Reduced 6.86%	79,271 $28 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $6.87 Million - $8.19 Million	-26,694 Reduced 23.88%	85,107 $24.7 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $6.22 Million - $8.8 Million	23,927 Added 27.23%	111,801 $30.6 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $7.64 Million - $8.56 Million	24,835 Added 39.4%	87,874 $28 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $17.7 Million - $20.8 Million	63,039	63,039 $19.7 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account